Press and Media Center

*Disclaimer:

The press releases above may include conclusions about Antimicrobial Copper that do not reflect EPA product registration approvals. The conclusions reached in these articles are the opinions of the researchers and authors. U.S. EPA-approved testing demonstrates efficacy of Antimicrobial Copper surfaces against only the following organisms: Staphylococcus aureus, Enterobacter aerogenes, Escherichia coli O157:H7, Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococcus faecalis (VRE). Any reference to effectiveness against other organisms has not been proven by U.S. EPA-approved testing.  No claim of antimicrobial effectiveness is made, either express or implied, with regard to organisms other than those identified above. Further, any references that state or imply effectiveness in controlling disease or the transmission of bacteria that can cause disease in humans have not been approved by the U.S. EPA or FDA. Antimicrobial Copper surfaces cannot make "infectious disease control" claims. Antimicrobial Copper surfaces have been shown to reduce microbial contamination, but they do not necessarily prevent cross contamination.